{
  "id": 2662826,
  "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
  "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-2662826",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-22T21:42:01.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/insider-transaction-cytokinetics-ceo-robert-blum-sells-7500-shares-575700"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsThe transaction involved the disposal of 7,500 shares.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
        "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares-2661251",
        "published": "2026-08-22T21:22:01.000Z"
      },
      {
        "outlet": "Yahoo Finance",
        "title": "Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700",
        "url": "https://urgent.news/2026/08/22/insider-transaction-cytokinetics-ceo-robert-blum-sells-7-500-shares",
        "published": "2026-08-22T21:42:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}